GEMMA KAUNERT: Open Payments
NPI 1962697482 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 28 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,008
Food & beverage: $896Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $855 |
| Neurocrine BioSciences, Inc. | 2 | $136 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: AUSTEDO XR, INGREZZA, REXULTI.
Industry payments across NY — which companies pay providers there.
